COA most commonly stands for Certificate of Analysis, a lab report that verifies what’s actually in a product. You’ll encounter this term most often when shopping for CBD or hemp products, dietary supplements, or other goods where independent testing confirms purity and potency. In medicine, COA can also refer to coarctation of the aorta, a congenital heart defect. Here’s what you need to know about both.
Certificate of Analysis: The Basics
A Certificate of Analysis is a document issued by a laboratory that details exactly what a product contains and whether it meets safety standards. It lists the results of tests performed on a specific batch, covering things like active ingredient levels, contamination screening, and whether the product matches what’s printed on its label. If you’ve seen “COA” on a CBD product page or supplement bottle, this is what it refers to.
COAs exist because labels can be misleading or outright wrong. A product might claim to contain 1,000 mg of CBD, but without third-party testing, there’s no way to verify that. The COA bridges that gap by providing actual measured values from an independent lab, not just the manufacturer’s claims.
What a COA Typically Includes
A useful COA covers several categories of testing. The most important for consumers are potency (how much of the active ingredient is present), contaminant screening, and whether the product matches its label claims. For CBD and hemp products specifically, a COA should report cannabinoid concentrations, terpene profiles, and screening results for heavy metals, pesticides, residual solvents, and microbial contaminants like mold.
Heavy metal testing typically checks for lead, mercury, cadmium, and arsenic. These metals can accumulate in hemp plants grown in contaminated soil. A 2020 study of 29 commercial hemp supplements found that two products exceeded regulatory limits for safe oral consumption: one contained arsenic levels far above the threshold, and another had lead concentrations that would fail both laboratory guidelines and U.S. Pharmacopeia standards. These are exactly the kinds of problems a COA is designed to catch.
You’ll also see two technical terms on many COAs: LOD and LOQ. The limit of detection (LOD) is the lowest concentration of a substance the lab can reliably identify as present. The limit of quantitation (LOQ) is the lowest concentration the lab can accurately measure with a specific number. If a contaminant shows up as “below LOD,” it means the lab didn’t detect it at all. If it reads “below LOQ,” the substance was detected but at levels too low to measure precisely. Both are generally good signs for contaminants you don’t want in your product.
How to Tell if a COA Is Trustworthy
Not all COAs carry the same weight. The most reliable ones come from labs accredited under ISO/IEC 17025, the international standard for laboratory competence. This accreditation means the lab’s testing methods have been independently verified for accuracy, reliability, and consistency. Labs that hold this accreditation follow standardized, reproducible processes and undergo regular audits. Look for the accreditation seal or lab credentials on the COA itself.
A credible COA should include the name of the testing lab, the date of testing, the specific batch number tested, the methods used, and the actual numerical results rather than just pass/fail designations. If a company only provides a COA with no lab name, no batch number, or results that are suspiciously vague, treat it with skepticism.
COAs for Dietary Supplements
Federal regulations require dietary supplement manufacturers to verify the identity, purity, strength, and composition of every ingredient they use. Under FDA rules (21 CFR Part 111), manufacturers must either test components themselves or rely on a supplier’s Certificate of Analysis. If they use a supplier’s COA, they first have to qualify that supplier by independently confirming the supplier’s test results. The COA must describe the testing methods used, the acceptable limits, and the actual results obtained.
Manufacturers also must set limits on contamination levels that could compromise the finished product’s quality. This means a properly issued COA for a supplement ingredient isn’t just a formality. It’s a regulatory requirement with specific documentation standards behind it.
Coarctation of the Aorta: The Medical Meaning
In cardiology, COA (often written CoA) stands for coarctation of the aorta, a congenital heart defect where the body’s main artery, the aorta, is abnormally narrow at one point. The narrowing typically occurs at the isthmus, a specific spot just past where the artery branches off to supply the left arm. This is the region where a small fetal blood vessel called the ductus arteriosus once connected. After birth, tissue from that vessel can grow inward and constrict the aorta as it closes.
The narrowing forces the heart to pump harder to push blood past the tight spot, raising blood pressure in the upper body while reducing it in the lower body and legs. A blood pressure difference greater than 20 mmHg between the arms and legs suggests significant coarctation. Doctors check for this by measuring blood pressure in all four limbs simultaneously.
Treatment and Long-Term Outlook
Coarctation of the aorta has been treated surgically since the mid-20th century, with balloon angioplasty added as an option in 1982 and stent placement introduced in 1990. Surgery involves removing the narrowed section and reconnecting the aorta. Balloon angioplasty uses a catheter threaded through a blood vessel to inflate and widen the narrow segment. Stenting places a small mesh tube to hold the aorta open.
No randomized trials have directly compared surgery to stent placement, so the choice depends on the patient’s age, the anatomy of the narrowing, any associated heart defects, and the medical team’s expertise. Each approach carries risks: re-narrowing occurs in 3% to 4% of surgical patients, and small aneurysms develop in 4% to 7% of those who receive stents.
Even after successful repair, coarctation of the aorta requires lifelong monitoring. In a long-term follow-up study of adults who had the defect repaired, nearly half (48.3%) developed high blood pressure, about 26% experienced re-narrowing at the repair site, and roughly 14% developed widening of the aorta. Heart muscle thickening, a consequence of the heart working harder than normal, showed up in about 29% of patients. These numbers underscore that repair corrects the immediate obstruction but doesn’t eliminate cardiovascular risk entirely.